ANDA 83204, held by Watson Labs. Promethazine Hydrochloride.
As of Nov 16, 2026, ANDA 83204 (Promethazine Hydrochloride), held by Watson Labs, was first approved by FDA on Mar 6, 1973, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 6, 1973 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Promethazine Hydrochloride25MG ยท tablet;oral | Promethazine Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters